Print

Meda AB (MDABF.PK): Acnex Filed in Europe  
4/19/2011 10:47:08 AM

GÖTEBORG, Sweden--(BUSINESS WIRE)-- The marketing authorization application for Acnex (clindamycin with tretinoin) has been submitted to the European regulatory authorities. Acnex is a new product for treatment of mild to severe acne vulgaris. It’s patented and formulated as a once-daily gel. More than 4,000 patients have been included in clinical studies.
//-->